Wikipedia -WSS

Wikipedia

author：hotspot 2025-09-06 03:26:36 - browse：875

SAN DIEGO — One of the toughest subtypes of acute leukemia involves a genetic alteration in the KMT2A gene. Many cancers with this genetic alteration end up relapsing or don’t respond to treatment, but new data presented at the annual American Society of Hematology meeting offer hope of a new targeted therapy for these patients.

The study, called the Phase 2 Augment-101 trial, tested Syndax’s revumenib in patients with relapsed or refractory leukemia with these KMT2A genetic rearrangements. Overall, about 63% of the patients responded to the treatment, with many able to receive a potentially curative stem cell transplant later on, which is often the ultimate goal for patients with relapsed or refractory patients, said Ibrahim Aldoss, a hematologist-oncologist at City of Hope and the study’s presenter, in an interview.

“KMT2A-rearranged diseases represent 10% of all leukemia. They can be exceptionally hard to treat,” Aldoss said. “The median overall survival remains low with current available treatment. Right now there’s no targeted therapy for KMT2A-rearranged disease. We’re really excited about revumenib as it targets the mutation, and we’re seeing encouraging outcomes.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： For Cytokinetics, FDA rejection of heart drug would help, not hinder

WSS

Continuity nursing helped my family in our darkest PICU moments

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Why failed clinical trials don’t always spell doom for a new drug

FDA approval of Sarepta Duchenne genetic therapy gives me hope

American woman, child freed after being kidnapped in Haiti last month

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

entertainment

Wikipedia

focus

23andMe had bad news about my health. I wish a person had delivered it

The cancer drug shortage isn’t new — and neither are the solutions

Hepatitis C has a cure — but many Americans still lack access to it

Why failed clinical trials don’t always spell doom for a new drug

New air purifier tech could be key to improving indoor air quality

BioMarin wins approval for gene therapy to treat hemophilia A

Jerome Adams on the need for new antivirals for Covid

Police still searching for prisoner who escaped from NYC hospital

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Heart attack and stroke risk calculators need revising

Wikipedia

Drastic changes should bring profitability, startup health insurers say

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The best solution to the drug shortages problem

As demand for Covid shots wanes, Moderna seeks its next success

What to know about Virgin Galactic's 1st mission taking paying customers to space

What to know about Virgin Galactic's 1st mission taking paying customers to space

hotspot

hotspot

focus

focus